IRTCiRhythm Holdings, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $747M
- 26% YoY
- Operating margin
- -7.7%
- 61% YoY
- EBITDA
- −$37M
- 61% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$212M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired12% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $323M | $411M | $493M | $592M | $747M | 26% |
| Operating income | −$100M | −$114M | −$125M | −$116M | −$57M | 50% |
| Net income | −$101M | −$116M | −$123M | −$113M | −$45M | 60% |
| Operating cash flow | −$38M | −$23M | −$50M | $3M | $81M | 2285% |
| Capex | $28M | $30M | $40M | $34M | $46M | 37% |
| Stock-based comp | $55M | $58M | $77M | $76M | $88M | 16% |
| Buybacks | — | $0 | $0 | $25M | $0 | 100% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $5M · 4
- Net
- −$5M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 75 | 79 |
| FY2024 | — | — | 38 | 79 |
| FY2023 | — | — | 45 | 75 |
| FY2022 | — | — | 39 | 79 |
| FY2021 | — | — | 50 | 104 |